作者：
A,Moreira [1]
;
J,Masliah-Planchon [2]
;
C,Callens [3]
;
S,Vacher [4]
;
C,Lecerf [5]
;
M,Frelaut [6]
;
E,Borcoman [7]
;
N,Torossian [8]
;
F,Ricci [9]
;
S,Hescot [10]
;
M P,Sablin [11]
;
P,Tresca [12]
;
D,Loirat [13]
;
S,Melaabi [14]
;
O,Trabelsi-Grati [15]
;
G,Pierron [16]
;
D,Gentien [17]
;
V,Bernard [18]
;
A,Vincent Salomon [19]
;
N,Servant [20]
;
I,Bieche [21]
;
C,Le Tourneau [22]
;
M,Kamal [23]
作者单位：
Department of Drug Development and Innovation (D3i), Institut Curie, Paris, Saint-Cloud, France. Electronic address: aurelie.moreira@curie.fr.
[1]
Department of Genetics, Institut Curie, PSL Research University, Paris, France. Electronic address: julien.masliahplanchon@curie.fr.
[2]
Department of Genetics, Institut Curie, PSL Research University, Paris, France. Electronic address: celine.callens@curie.fr.
[3]
Department of Genetics, Institut Curie, PSL Research University, Paris, France. Electronic address: sophie.vacher@curie.fr.
[4]
Department of Drug Development and Innovation (D3i), Institut Curie, Paris, Saint-Cloud, France. Electronic address: charlotte.lecerf@curie.fr.
[5]
Department of Drug Development and Innovation (D3i), Institut Curie, Paris, Saint-Cloud, France. Electronic address: maxime.frelaut@curie.fr.
[6]
Department of Drug Development and Innovation (D3i), Institut Curie, Paris, Saint-Cloud, France. Electronic address: edith.borcoman@curie.fr.
[7]
Department of Drug Development and Innovation (D3i), Institut Curie, Paris, Saint-Cloud, France. Electronic address: nouritza.torossian@curie.fr.
[8]
Department of Drug Development and Innovation (D3i), Institut Curie, Paris, Saint-Cloud, France. Electronic address: francesco.ricci@curie.fr.
[9]
Department of Drug Development and Innovation (D3i), Institut Curie, Paris, Saint-Cloud, France. Electronic address: segolene.hescot@curie.fr.
[10]
Department of Drug Development and Innovation (D3i), Institut Curie, Paris, Saint-Cloud, France. Electronic address: mariepaule.sablin@curie.fr.
[11]
Department of Drug Development and Innovation (D3i), Institut Curie, Paris, Saint-Cloud, France. Electronic address: patricia.tresca@curie.fr.
[12]
Department of Drug Development and Innovation (D3i), Institut Curie, Paris, Saint-Cloud, France. Electronic address: delphine.loirat@curie.fr.
[13]
Department of Genetics, Institut Curie, PSL Research University, Paris, France. Electronic address: samia.melaabi@curie.fr.
[14]
Department of Genetics, Institut Curie, PSL Research University, Paris, France. Electronic address: olfa.trabelsigrati@curie.fr.
[15]
Department of Genetics, Institut Curie, PSL Research University, Paris, France. Electronic address: gaelle.pierron@curie.fr.
[16]
Department of Translational Research, Institut Curie, PSL Research University, Paris, France. Electronic address: david.gentien@curie.fr.
[17]
Department of Genetics, Institut Curie, PSL Research University, Paris, France. Electronic address: Virginie.Bernard@curie.fr.
[18]
Department of Pathology, Institut Curie, PSL Research University, Paris, France. Electronic address: anne.salomon@curie.fr.
[19]
INSERM U900, Institut Curie, Mines Paris Tech, Paris, France. Electronic address: nicolas.servant@curie.fr.
[20]
Department of Genetics, Institut Curie, PSL Research University, Paris, France; INSERM U1016 Research Unit, Cochin Institute, Paris, France. Electronic address: ivan.bieche@curie.fr.
[21]
Department of Drug Development and Innovation (D3i), Institut Curie, Paris, Saint-Cloud, France; INSERM U900, Institut Curie, Mines Paris Tech, Paris, France; Paris-Saclay University, Paris, France. Electronic address: christophe.letourneau@curie.fr.
[22]
Department of Drug Development and Innovation (D3i), Institut Curie, Paris, Saint-Cloud, France. Electronic address: maud.kamal@curie.fr.
[23]
DOI
10.1016/j.ejca.2019.09.001
PMID
31593830
发布时间
2020-06-08
换一批
换一批
